Catalyst Oncology Solutions
-
Purposed-Built For ADC Development
10/17/2025
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
-
Purpose-Built For ADC Development
10/9/2025
Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody targeting with potent payloads to improve patient outcomes.
-
Operationalizing Global Oncology Trials
10/2/2025
Catalyst Oncology accelerates innovation by aligning strategic insight, deep expertise, and flawless execution. With global reach, we fast-track development timelines through a seamlessly integrated approach, empowering biotechs to deliver life-changing therapies to patients worldwide—faster, smarter, and with purpose.
-
Developing Cutting-Edge Treatments For Ovarian Cancer
9/17/2025
Developing cutting-edge treatments for ovarian cancer requires specialized expertise and a people-first approach to research.
-
Oncology CRO Helping To Bring Cancer Therapies To Patients
9/5/2025
Niche CRO with a difference
Catalyst Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.